灵长类逆转录因子外显子和两性二态IL13RA1转录调节2型免疫应答

IF 16.3 1区 医学 Q1 IMMUNOLOGY
Tobias Plowman, Tom Hofland, Callum Hall, Rachael Thompson, Judith Pape, Kevin W. Ng, Laura Doglio, George Kassiotis
{"title":"灵长类逆转录因子外显子和两性二态IL13RA1转录调节2型免疫应答","authors":"Tobias Plowman,&nbsp;Tom Hofland,&nbsp;Callum Hall,&nbsp;Rachael Thompson,&nbsp;Judith Pape,&nbsp;Kevin W. Ng,&nbsp;Laura Doglio,&nbsp;George Kassiotis","doi":"10.1126/sciimmunol.adr1105","DOIUrl":null,"url":null,"abstract":"<div >Type 2 immunity is orchestrated by IL-4 and IL-13 signaling, initiated by binding to receptors that are specific to each cytokine or to the shared heterodimeric receptor comprising the IL-4Rα and IL-13Rα1 subunits. Here, we report that sexually dimorphic <i>IL13RA1</i> transcription is regulated by estrogen and characterize an IL-13Rα1 isoform (referred to here as IL-13Rα1–LOR1a) created through facultative splicing to an alternative terminal exon composed of primate-specific retrotransposable elements (RTEs). At the mRNA level, RTE exonization replaces regulatory sequences in the canonical 3′ untranslated region (3′UTR) implicated in <i>IL13RA1</i> mRNA stability. Moreover, alternative splicing removes critical domains in the cytoplasmic tail, rendering the IL-13Rα1–LOR1a isoform partially signaling defective at the protein level. When coexpressed, the IL-13Rα1–LOR1a isoform antagonizes the function of the canonical receptor, reducing cellular responsiveness to IL-4 and IL-13. Thus, the balance of the two <i>IL13RA1</i> isoforms appears to fine-tune type 2 cytokine signaling and downstream immune responses.</div>","PeriodicalId":21734,"journal":{"name":"Science Immunology","volume":"10 109","pages":""},"PeriodicalIF":16.3000,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Primate retroelement exonization and sexually dimorphic IL13RA1 transcription tune type 2 immune responses\",\"authors\":\"Tobias Plowman,&nbsp;Tom Hofland,&nbsp;Callum Hall,&nbsp;Rachael Thompson,&nbsp;Judith Pape,&nbsp;Kevin W. Ng,&nbsp;Laura Doglio,&nbsp;George Kassiotis\",\"doi\":\"10.1126/sciimmunol.adr1105\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div >Type 2 immunity is orchestrated by IL-4 and IL-13 signaling, initiated by binding to receptors that are specific to each cytokine or to the shared heterodimeric receptor comprising the IL-4Rα and IL-13Rα1 subunits. Here, we report that sexually dimorphic <i>IL13RA1</i> transcription is regulated by estrogen and characterize an IL-13Rα1 isoform (referred to here as IL-13Rα1–LOR1a) created through facultative splicing to an alternative terminal exon composed of primate-specific retrotransposable elements (RTEs). At the mRNA level, RTE exonization replaces regulatory sequences in the canonical 3′ untranslated region (3′UTR) implicated in <i>IL13RA1</i> mRNA stability. Moreover, alternative splicing removes critical domains in the cytoplasmic tail, rendering the IL-13Rα1–LOR1a isoform partially signaling defective at the protein level. When coexpressed, the IL-13Rα1–LOR1a isoform antagonizes the function of the canonical receptor, reducing cellular responsiveness to IL-4 and IL-13. Thus, the balance of the two <i>IL13RA1</i> isoforms appears to fine-tune type 2 cytokine signaling and downstream immune responses.</div>\",\"PeriodicalId\":21734,\"journal\":{\"name\":\"Science Immunology\",\"volume\":\"10 109\",\"pages\":\"\"},\"PeriodicalIF\":16.3000,\"publicationDate\":\"2025-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Science Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.science.org/doi/10.1126/sciimmunol.adr1105\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.science.org/doi/10.1126/sciimmunol.adr1105","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

2型免疫由IL-4和IL-13信号传导调控,通过与每种细胞因子特异性受体或由IL-4Rα和IL-13Rα1亚基组成的共享异二聚体受体结合而启动。在这里,我们报告了两性二态IL13RA1转录受雌激素调节,并表征了IL-13Rα1同种异构体(这里称为IL-13Rα1 - lor1a)通过兼性剪接到由灵长类特异性反转录转座元件(rte)组成的另一个末端外显子上产生。在mRNA水平上,RTE外显子化取代了与IL13RA1 mRNA稳定性相关的规范3 ‘非翻译区(3 ’ utr)中的调控序列。此外,选择性剪接去除细胞质尾部的关键结构域,使IL-13Rα1-LOR1a亚型在蛋白质水平上部分信号传导缺陷。当共表达时,IL-13Rα1-LOR1a亚型拮抗典型受体的功能,降低细胞对IL-4和IL-13的反应性。因此,两种IL13RA1亚型的平衡似乎可以微调2型细胞因子信号传导和下游免疫反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Primate retroelement exonization and sexually dimorphic IL13RA1 transcription tune type 2 immune responses
Type 2 immunity is orchestrated by IL-4 and IL-13 signaling, initiated by binding to receptors that are specific to each cytokine or to the shared heterodimeric receptor comprising the IL-4Rα and IL-13Rα1 subunits. Here, we report that sexually dimorphic IL13RA1 transcription is regulated by estrogen and characterize an IL-13Rα1 isoform (referred to here as IL-13Rα1–LOR1a) created through facultative splicing to an alternative terminal exon composed of primate-specific retrotransposable elements (RTEs). At the mRNA level, RTE exonization replaces regulatory sequences in the canonical 3′ untranslated region (3′UTR) implicated in IL13RA1 mRNA stability. Moreover, alternative splicing removes critical domains in the cytoplasmic tail, rendering the IL-13Rα1–LOR1a isoform partially signaling defective at the protein level. When coexpressed, the IL-13Rα1–LOR1a isoform antagonizes the function of the canonical receptor, reducing cellular responsiveness to IL-4 and IL-13. Thus, the balance of the two IL13RA1 isoforms appears to fine-tune type 2 cytokine signaling and downstream immune responses.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Science Immunology
Science Immunology Immunology and Microbiology-Immunology
CiteScore
32.90
自引率
2.00%
发文量
183
期刊介绍: Science Immunology is a peer-reviewed journal that publishes original research articles in the field of immunology. The journal encourages the submission of research findings from all areas of immunology, including studies on innate and adaptive immunity, immune cell development and differentiation, immunogenomics, systems immunology, structural immunology, antigen presentation, immunometabolism, and mucosal immunology. Additionally, the journal covers research on immune contributions to health and disease, such as host defense, inflammation, cancer immunology, autoimmunity, allergy, transplantation, and immunodeficiency. Science Immunology maintains the same high-quality standard as other journals in the Science family and aims to facilitate understanding of the immune system by showcasing innovative advances in immunology research from all organisms and model systems, including humans.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信